Philip Morris International (PM) has recently experienced mixed reviews in stock performance according to various reports. Primarily, the organization has undergone a reduction in rating by Wall Street Zen, yet it garners significant institutional ownership of about 82%. Driven by the growth of smokeless innovations in Zyn and Iqos Iluma, PM is still on the radar for many partners and stakeholders with an increased stock position by entities such as Oregon Public Employees Retirement Fund, Benjamin Edwards Inc., and Spirepoint Private Client LLC, among others.
Meanwhile, there's speculation around a 21% trading discount, and PM's ESOP-funded shift to smoke-free products comes with market skepticism and is testing investor patience. News on the purchasing and selling of shares emerge from various organizations, including Nisa Investment Advisors LLC, Commonwealth Equity Services LLC and others. The company's past performance showed a considerable gain of 153% if invested five years ago. The company is on the verge of declaring a regular quarterly dividend of $1.47 per share, and speculation arouses for possible 2026 growth risks, affecting PM stock.
Philip Morris International PM News Analytics from Wed, 02 Jul 2025 07:00:00 GMT to Sat, 10 Jan 2026 21:29:43 GMT - Rating 5 - Innovation -2 - Information 8 - Rumor -1
